financetom
Business
financetom
/
Business
/
BRIEF-Chord Energy Announces Strategic Acquisition Of Williston Basin Assets
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Chord Energy Announces Strategic Acquisition Of Williston Basin Assets
Sep 15, 2025 6:42 PM

Sept 15 (Reuters) - Chord Energy Corp ( CHRD ):

* CHORD ENERGY ANNOUNCES STRATEGIC ACQUISITION OF WILLISTON

BASIN

ASSETS

* CHORD ENERGY CORP ( CHRD ) - ACQUISITION VALUED AT $550 MILLION

* CHORD ENERGY ( CHRD )- DEAL EXPECTED TO BE ACCRETIVE TO ALL KEY

METRICS

INCLUDING CASH FLOW, FREE CASH FLOW AND NAV IN BOTH NEAR AND

LONG-TERM

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Will you be able to buy Trump Tower at auction? Not anytime soon
Will you be able to buy Trump Tower at auction? Not anytime soon
Mar 25, 2024
(Reuters) - New York state could start seizing Donald Trump's properties if he doesn't post a bond by Monday to cover a $454 million civil fraud judgment, but it may be well over a year before Trump Tower and other prized real estate holdings are on the chopping block. Seizing the former U.S president's sprawling real estate empire, which includes...
BioNTech gets notice from NIH on default on royalties
BioNTech gets notice from NIH on default on royalties
Mar 25, 2024
March 25 (Reuters) - BioNTech said on Monday it has received a notice from the U.S. National Institutes of Health over default in payment of royalties and other amounts it allegedly owed the agency. ...
Novo Nordisk to buy Cardior Pharmaceuticals for up to $1.1 billion
Novo Nordisk to buy Cardior Pharmaceuticals for up to $1.1 billion
Mar 25, 2024
COPENHAGEN (Reuters) - Denmark's Novo Nordisk on Monday said it has agreed to buy Cardior Pharmaceuticals for up to 1.03 billion euros ($1.11 billion) to strengthen its cardiovascular pipeline. The acquisition is in line with the Danish drugmaker's aim to expand its focus on diabetes and weight-loss therapies to include cardiovascular disease treatments. By welcoming Cardior as a part of...
NGEx Minerals' Q4 Net Loss Holds Steady YOY
NGEx Minerals' Q4 Net Loss Holds Steady YOY
Mar 25, 2024
06:18 AM EDT, 03/25/2024 (MT Newswires) -- NGEx Minerals Ltd. ( NGXXF ) , near 52-week highs, over the weekend reported a fourth-quarter 2023 net loss of $8.6 million, or $0.04 per share, compared with $8.0 million, or $0.04 per share, in the year-ago quarter. As at Dec. 31, 2023, the company had cash of $59.5 million and net working...
Copyright 2023-2026 - www.financetom.com All Rights Reserved